DNA Aptamer against MCF-7 Breast Cancer Cells

DNA Aptamer against MCF-7 Breast Cancer Cells

$249.00$629.00

DNA Aptamers against MCF-7 Breast Cancer Cells

SKU: APT-065 Category:

Background

MCF-7 (Michigan Cancer Foundation-7) is a breast cancer cell line isolated in 1970 from a 69-year-old White woman and was established in 1973 by Herbert Soule and co-workers. MCF-7 breast cancer cell line retained several characteristics of differentiated mammary epithelium, including the ability to process estradiol via cytoplasmic estrogen receptors and the capability of forming domes. Tumor necrosis factor alpha (TNF alpha) inhibits the growth of MCF-7 breast cancer cells. Treatment with anti-estrogens can modulate the secretion of insulin-like growth factor binding proteins. Omega-3 and 6 fatty acids such as EPA, DHA and AA, have been reported to inhibit MCF-7 cell line growth and proliferation. PIK3CA helical mutations were identified in MCF-7, but with low AKT activation.

Fusion BioLabs provides validated DNA aptamer against MCF-7 breast cancer cell line.

 

Product Specification

Aptamer type: DNA aptamer

Aptamer length: 26 bp

Affinity KD: 30-50 nM by Cell-SELEX

Storage: keep at -20°C. DNA aptamers are guaranteed stable for 12 months when properly stored.

Weight 0.5 lbs
Dimensions 1 × 1 × 1 in
Size

10 nmol, 30 nmol

DOCUMENTATION

Data Sheet

Aptamer Development Services

Nucleic Acid AptamersFind Better Aptamers using Structured Aptamer LibrariesLearn More
Magnetic beads-based SELEXFind DNA/RNA Aptamers against Targets Immobilized on Magnetic BeadsLearn More
Capture-SELEXFind DNA/RNA Aptamers Using Immobilized Aptamer LibraryLearn More
Cell-SELEXIdentify either Cell-Surfaced or Cell-Internalized DNA/RNA Aptamers Learn More
Peptide AptamersIdentify Peptide Aptamers Using Beads-Based Phage Panning PlatformLearn More
Aptamer-based Biomarker DiscoveryDiscover Biomarkers Using Aptamer-Facilitated PlatformsLearn More